ABSTRACT Within-laboratory collaborative projects wherein each worker performs the technique he or she does best are common nowadays. Opportunities for projects wherein everyone does everything are less common, but these projects bring their own satisfactions; the Great Translocation Hunt is presented as an example.
ARGE laboratories with graduate students and postdoctoral fellows working on interwoven projects is the norm nowadays, but it was not always so; through most of the history of genetics, one could expect to train no more than, say, five youngsters throughout one's entire career. (There were of course exceptionsMorgan's original Fly Room, for example.) Of course, by or before the end of our training, we are supposed to have developed into independent scientists, capable not only of performing our procedures reliably but also of planning and interpreting them ourselves. But we still need someone to talk to; and, although of course good conversations can occur between levels, the best ones are between peers. To pick one example, only between peers can one gripe freely. Griping up risks being taken seriously and labeled a complainer; griping down should not be done. One reason why not is that griping is often about other people. Gripes about people can be let off to lay people or peers in different scientific areas, but scientific gripes require a peer with sufficient understanding of the problem to be sympathetic but not concerned. Another example is constructive criticism of one's ideas, hypotheses, and interpretations; here, it's fine to ask up, but what if there is no ''up''? A peer is the best one can do, and the more senior one gets, the harder it is to obtain helpful criticism.
Working in an interwoven project has its pros and cons. Yes, there are peers to talk the trivia over with, but getting a group all of whom pull their own weight is rare; this inequality creates a tension I prefer to avoid, and this is one reason why I normally work alone on my projects. The exceptions, however, are projects where there is a single line of experimentation that needs more than two hands to handle the load; everyone is doing the same thing at any point, and inequalities are less of a problem (as long as n is greater than 2). When this works, there is no (scientific) joy greater. I have been privileged to share in four such projects during my career. The first and third were with Bruce Baker [the meiotic mutant hunt (Baker and Carpenter 1972) and the mitotic defects of those meiotic mutants (Baker et al. 1978) ], the fourth was with Fotos Kafatos (eventually published as Barrio et al. 1999) , getting the mutations for what would eventually be named salr (spalt related) as well as spalt, and the second, the Great Translocation Hunt led by Dan L. Lindsley and Larry Sandler (Lindsley et al. 1972) , which involved the massed might of both the Sandler and Lindsley laboratories, is the subject of this article.
Background: Dan Lindsley and Larry Sandler met in Ed Novitski's lab, Dan as a postdoc and Larry as a graduate student. Apparently they immediately began doing joint projects (the various compound X papers); certainly they worked well together and enjoyed doing so, because later they went on sabbaticals together whenever they could. In fact, Larry had just returned from one such (with Nicoletti and Trippa as well as Dan in Rome, isolating recessive autosomal meiotic mutations from wild-caught flies, Sandler et al. 1968) when I joined Bruce for what we laughingly thought was a summer's side project in 1969-inducing X-linked meiotic mutants with the then brand-new chemical mutagen EMS (Baker and Carpenter 1972) . Bruce already had a thesis project (pal, paternal loss, Baker 1975) when we started this highly successful project, but when it came time to write his thesis the pal project still had a few large experiments outstanding so he defended the mutant hunt instead, and a year later I defended the analysis of the unique female meiotic mutant nod (no distributive disjunction). The rest of the female meiotics were recombination defective and interesting in their own right, but the existence of nod settled a controversy: if one can get a mutant defective in distributive disjunction, then the distributive system (a system for getting correct meiosis I segregation even when chiasmata are absent) does exist (Carpenter 1973) .
But the Rome experience had not satisfied Dan and Larry's need for joint science; and, after all, waiting seven years to get together with your most important colleague is rather a long time. Dan had realized that, if enough translocations could be induced and mapped, deficiencies and the reciprocal duplications of various sizes could be synthesized at will by meiotic segregation whether or not they were viable-and that viability information would be interesting. It had long been known that small (a salivary chromosome number division or so) deficiencies could be recovered relatively easily though large ones were not recovered; either the genome is peppered with genes that must be present in two doses for viability, so any large deficiency will take out at least one such gene, or else all or most genes have small effects on viability when present in only one dose, cumulatively, so that the larger the deficiency, the lower its viability. With enough translocations one could march along a chromosome arm making deficiencies and duplications that were absolutely adjacent, guaranteed to identify all genes whose dosage mattered to the phenotype of the fly (a number of such genes were already known), and, just possibly, build a resource useful to the fly community in general. But to get that many translocations needed many hands, so the plan of joining laboratories was born: first the La Jolla group came up to Seattle for the summer of 1970 and we all induced and scored for translocations, then we separated and both groups did translocation cytology during the autumn, then the Seattle group went down to La Jolla for 4 weeks over Christmas to score the crosses generating the deficiencies and duplications, followed by data analysis and writing. But first, a digression on how this setup works.
How the translocations were used: Take three Y-autosome translocations (Figure 1 ) with autosomal breakpoints A, B, and C that are near each other; cross them as heterozygotes in all combinations. Translocation heterozygotes give many kinds of gametes, and there were enough markers in the crosses so that all types of segregation were scorable, but the important progeny are shown in Figure 1 : the autosomal deficiency between the breakpoints of A and B and its exact duplication, the exactly adjacent deficiency between B and C and its exact duplication, and the sum deficiency and its exact duplication between A and C. Not shown are the euploid sibs against which the viability of the aneuploids is measured. These aneuploids are also duplicated or deficient for Y chromosome material, but Y-material aneuploidy has negligible effect on viability so can be ignored. There is one small caveat about the sum deficiencies: they may be slightly smaller than just adding the effects of the two component deficiencies, because the middle (B) breakpoint may be slightly larger than a point-in particular, the juxtaposition of Y heterochromatin and autosomal euchromatin will usually give some inactivation of the euchromatin from position-effect variegation. Fortunately, this did not complicate analyzing the results.
This distinguishes between the above two alternatives: if larger deficiencies die because they delete a gene required in two doses, then every lethal sum deficiency will have one or both component deficiencies lethal too, whereas if cumulative effects of many genes cause the sum deficiency lethality, then cases where the sum deficiency is lethal but both component deficiencies are viable should exist.
How the translocations were made: So the La Jolla group drove to Seattle for the summer, bringing a newlypurchased Zeiss Ultraphot light microscope; the stocks needed to induce and balance Y-autosome translocations had been mailed ahead for expansion. But the stock building had been a bit last minute-probably the whole idea had been a bit last minute-and Dan just barely had various versions of the necessary stocks built; he had not had time to see which were the healthiest. Sets of these stocks were handed out to us grad students; I received the second-chromosome stocks to baby and expand. However, although I had been handling flies for a year by then, all that work had been on the X; the second chromosome and its balancers were new to me. And, in 1970, there was no easy way to look anything up! The book by Bridges and Brehme (1944) was unobtainable and out of date anyway, Lindsley and Grell (1968) was not available yet (at least in the Sandler laboratory, though I bought my own copy soon after), and of course FlyBase was not yet remotely conceived of. The only way to find things out was to ask someone more experienced-and I did not think I needed to. After all, all the stocks were Curly (Cy), I could see the curved wings, and I must have thought that 2L12R Cy, SM1 Cy, and CyO were just three different attempts to make the same stock rather than the reality, three different secondchromosome balancers so that the one that made the best stock could be chosen for use. CyO was the best available second-chromosome balancer at the time but it also has the lowest fertility, SM1 is intermediate, and 2L12R Cy is the most fertile but the poorest balancer. Since I thought those three bottles were different isolates of the same stock, and since none of them were going particularly well, I merged them, and I did succeed in expanding the result as a healthy stock. I was quite proud of my accomplishment until Dan asked which of the three it was! He was very nice about it. Of course, the most-fertile 2L12R Cy chromosome had succeeded in taking over the stock by the time my mistake was noticed. This did have downstream effects: the ultimate balanced Y-second translocation stocks were more likely to break down by crossing over and lose the translocation than those for the third; but on the other hand, we might well have had to use 2L12R Cy anyway, because neither SM1 nor CyO go well in stocks that have additional aberrations.
Getting the translocations was simple. Males carrying a Y with dominant markers at the tip of each arm but otherwise wild type were irradiated and crossed to females homozygous for the two eye color mutations brown (bw, second) and scarlet (st, third); each son of this cross is potentially carrying a Y-autosome translocation, say T(Y;2), 1/bw; 1/st. Crossing each such male back to bw; st females detects translocations by linking eye color to sex; if there is no translocation, both sons and daughters can be wild type, brown, scarlet, or both brown and scarlet (eyes are white); for the T(Y;2) above, all daughters are brown (6 scarlet) and all sons are bw 1 (6 scarlet). (Reality of course is not quite this simple, but Dan had thought of all possible complications and the actual crosses covered all of them; if you think you see such a complication, refer to the article to find out how Dan solved it.) The progeny of the test cross make a temporary stock, since the only free Y that came into the cross had the translocation so all Y-bearing progeny will have the autosome physically linked to it, but to be able to detect the ultimate deficiencies and duplications, more complicated stocks needed to be made: in particular, all Y;Autosome translocations had to be put into females too, since crossing males by males is a fruitless operation (this was done by crossing to an attached-X, giving att-X/T(Y;A) females).
So the first phase of this project, in Seattle during the summer of 1970, involved inducing the translocations, detecting them, and making the stocks to be used. From La Jolla we had Dan, Rob Denell, Pat Jacobs, and George Miklos; from Seattle we had Larry, Bruce, Jeff Hall, Dilys Parry, Steve Miller, Hiroshi Nozawa, and me. This was a constant flow-through process; each week a batch of males was irradiated and crossed, the 2-week's previous irradiated males' sons were crossed to test for translocations, and the 4-week's previous translocation tests were scored. And everyone did all phases (sometimes with a little too much overlap; I remember being amazed at how young all the flies were at one of my 12-hour virgin collections, only to be told by Rob Denell that he had already collected from that set earlier that morning), with a few exceptions (Bruce Baker's colorblindness is usually an asset in scoring fly eye colors but he turned out to be random with respect to bw vs. bw 1 in the very small eye of B S , so he was excused from the step where that was crucial).
And the highlight of the week was the weekly strategy session, during which we each reported progress and planned the next week and, most importantly, discussed problems and how to solve them. Dan and Larry forbore meeting separately; from the time the La Jolla group got to Seattle all discussions of strategy were communal. I found having participated in the planning and running of this project to be an enormous boost to learning how to plan and run my own projects.
The major aspect of the progress report was how many translocations each of us had found the past week; we got to name the ones we found with our own initial plus the sequential number. Of course there was friendly rivalry, at least early on, for who had found the most that week, but it soon became clear that we The aneuploids; Bal, Balancer chromosome; Df, deficiency; and Dp, duplication. Vertical ticks on the Balancer chromosome mark where the breakpoints are for the translocations; most of arm 3R is left off to simplify the diagram. The upper far left diagram has only one copy of the genome between the A and B breakpoints (on the Balancer), whereas the rest of chromosome 3 is in two doses; these zygotes are therefore deficient for the A-B interval and their (adult) viability is measured relative to their euploid sibs (not shown). Note that this deficiency can be regularly produced by segregation independently of its ultimate viability, therefore letting its viability be measured. The lower left diagram has three copies of the A-B interval against the two copies of the rest of chromosome 3 and is therefore duplicated for this interval. Note that the A-B deficiency is exactly adjacent to the B-C deficiency because they have the breakpoint of B in common and that the A-C deficiency is the exact sum of the smaller A-B and B-C deficiencies; ditto for the duplications.
were not equal in this regard! Bruce Baker took the lead early on and it just kept increasing. Obviously, the more test crosses one scores the more translocations one will find, and Bruce works fast, hard, and accurately, but also the trays he scored seemed to have more translocations. Just another indication of his golden hands, in my opinion.
There was another aspect of this summer that had farreaching effects on my career. Although Larry's lab did sport a compound microscope, it got as little use as the other machine Larry had considered part of the wellequipped fly lab (a device for counting large numbers of flies automatically: this made an interesting wall ornament); Larry considered anything having to do with cytology to be unimportant. Dan, on the other hand, was a highly skilled cytologist who reveled in the analysis of aberration breakpoints using the banding patterns of salivary gland chromosomes; he is also an excellent teacher. Since the next step in the translocation study involved finding out where their autosomal breakpoints were, we all learned how to do this from him during the summer. Being able to do the cytology of my own aberrations and check the cytology of others have been invaluable over the years-and besides which, it is fun! Moreover, being confident in one sort of cytology probably made my career move into electron microscopy a few years later easier.
Dan had us do the cytology of each translocation in pairs; two of us would each work up the breakpoints separately from our own preparations, then compare our results. If we agreed, fine, but if we did not we would both go back for additional examples (each clear example being drawn for the relevant region, with bands labeled with what we thought their Bridges' addresses were) until we did agree or agreed to disagree, roping in a third again to work it up independently. I don't remember, but it would have made sense for Dan to have paired himself up with each of us in turn during the summer's learning phase, both to hasten our learning and also to get a feel for our individual reliability; we did vary in this regard. Fortunately, high accuracy of the cytology was not essential, because adjacent deficiencies and duplications will still be adjacent even if the assignment of the middle, common breakpoint is slightly incorrect. However, at the end of the summer, Dan et al. went back to La Jolla leaving the Seattle contingent to muddle through on our own.
So we ended the summer with lots of T(Y;2)s and T(Y;3)s, in various stages of being stocked and having their cytology determined. Since the plan was to score the crosses between adjacent translocations over the following Christmas break, we needed to know the cytology and have proper stocks of as many of the translocations as we could before Christmas so that the appropriate crosses could be set up; getting this first phase finished had high priority. Dan chose to take the T(Y;2)s for cytology by himself, Pat and Rob in La Jolla, leaving the T(Y;3)s for mainly Bruce and me in Seattle.
This choice probably was not random; although the third chromosome has its difficult regions, it is much easier for salivary cytology than the second, which usually ties itself into ectopic knots (tight synapses each between ostensibly nonhomologous regions), both mimicking aberrations and also making working up the real breakpoint when it fell within an ectopically paired region very difficult. So we beavered away on the T(Y;3)s, communicating the breakpoints to La Jolla as we went (by snail mail, I presume), where a map of breakpoints along the arms was built up so that the best subset of inter-se crosses could be chosen.
How the translocations were crossed: Of course one could just cross everything with everything else, but that would be very wasteful; really large deficiencies and duplications (half an arm, say) will be lethal, regardless of why that lethality arises. At the other extreme, one could cross each translocation to the nearest on each side, but this would also very likely be wasteful, because our coverage was very nonuniform; although some regions had few breakpoints, others had lots-enough to make really tiny deficiencies indeed if all adjacent translocations were crossed. Since it was already known that many regions of the genome tolerate medium-sized deficiencies, an intermediate strategy was used; where possible, the smaller deficiencies were around 3 letter divisions, or 1/160 of total autosomal euchromatin-58 Mb of DNA-though some sparsely-covered regions had to settle for much larger ones. Recall that the point was to attempt to recover not only the basal deficiencies AB, BC, and CD, but also the larger sum deficiencies AC and BD, etc. The logic here is: if lethality of large deficiencies is typically from relatively rare dosagesensitive genes, then failure to recover the sum deficiencies AC and BD would most often be accompanied by failure to recover the should-be-small-enough common region of BC; if, on the other hand, that lethality is typically from the sum of small effects, then failure to recover a sum deficiency should most often be accompanied by viability of both its component smaller deficiencies. Just in case the logic of three letter divisions was flawed, two regions that had lots of breakpoints were chosen for saturation all-by-all crosses; this turned out to be useful for one of those regions. The La Jolla crew (Dan, Rob, Pat, George, Dick Gethmann, Bob Hardy, Anita Hessler, and Meredith Gould-Somero) did the heroic task of setting up the translocation-by-translocation crosses, timed to eclose over the Christmas break; the Seattle crew (Larry, Bruce, Jeff, Steve, Dilys, Brian Davis, and I) joined them; we took over a large teaching laboratory and used the student microscopes-all of us together in one room. Having lots of people trying to work in the same room without getting terminally on each other's nerves is commonplace now; it was not back then, at least not in fly labs. But we coped, and it was again a treat to be working with so many people all doing the same thing. Of course we each did the counts of all possible classes from each cross separately, but everyone else around could be counted on for advice, a second opinion on a questionable phenotype, or admiration of a novel phenotype.
We took Christmas Day itself off, for a luau on the beach (a cloudy, cold day for it, too). Nevertheless, Dan insisted that the water would be warm enough for bathing: the only person foolish enough to believe him was me! No, it was not, but in fairness he did get his own feet wet first.
The answer: We did get all the crosses completely scored in the time available (we did after all have to return the room and its microscopes to the undergraduates for the winter term) and we already had our answer, even without having all the score sheets totted up: there were many examples where both smaller deficiencies were viable but the sum was not, so typically large deficiencies die from cumulative effects of many small reductions in viability. This is also true for duplications, but because much larger duplications are tolerated than deficiencies, the relevant comparisons are terminal duplications vs. interstitial ones (all but one of which were viable). We identified all the known haplo-abnormal genes (those which give a phenotype with only one copy of the wild-type allele) and found some new ones, the most important class of which are Minutes (so named because they have short, thin bristles; body size is little if at all affected). Several Minute genes are now known to code for ribosomal proteins; probably most do, and the constellation of phenotypes of Minutes (delayed development, reduced bristles, female sterility, and often greatly reduced viability) are all consistent with compromised maximum protein synthesis-if there is upregulation of the sole remaining wild-type copy, this is not sufficient to meet all protein synthesis demands. One of the regions chosen for the saturation all-by-all crosses turned out to contain two Minute genes, both strong enough to reduce viability a lot; we needed the small, saturation setup to get any survivors and to place those Minutes.
The final category is one small region that is lethal both in one and three doses; the gene responsible for this unique phenotype has been named ''Triplo-lethal'' but its function has remained elusive.
We all contributed to the writing of the article, of course, mostly during the summer of 1971; my own major contribution was to figure out why terminal duplications for arm 2L were viable so much further along that arm than those of 2R, 3L, and 3R. (This is because there are fewer genes/bands in 2L, but Bridges gave it the same number of divisions as the other three; plotting viability against number of bands rather than number of divisions removes the disparity.) Order of authors was decreed from on high; first the two principal investigators; then the set of juniors who had contributed a lot, in alphabetical order; then the set of juniors who had contributed less, again in alphabetical order. Amusingly, this final order does reproduce very well the actual contributions of each of us to the overall work.
Other uses: Since we had produced stocks capable of generating deficiencies for most autosomal regions in a common genetic background, we hoped the fly community would take advantage of this resource, either for specific regions or, at the time possibly more usefully, to find the gene of your protein of interest by testing the series of deficiencies and duplications to find the region where the amount of your protein varies with the region's ploidy. Although a few workers did try to use this resource it did not attract wide interest. On the one hand, the few that tried to find their genes by dosage were typically frustrated both by some upregulation of the remaining wild-type copy and also by finding more than one affected region; on the other hand, the complication of the complex crosses needed to generate progeny, only some of which were the desired aneuploids, deterred many from trying. It is possible to simplify the crosses by first making a deficiency by segregation, then inducing a translocation between its two Y components so that this deficiency is now one chromosome rather than two and can therefore be stocked and used in crosses in the normal, straightforward manner, but this takes a lot of work for each and every deficiency. This was done for the few that someone had a special interest in, but no one was willing to devote the years to transform the lot. Consequently, this translocation collection never made a major impact on the greater fly community.
There are modern parallels: two groups independently hopped marked P elements engineered to make getting deficiencies between nearby inserts possible, picked up the viable inserts, and located them. However, one group went the next step and made the deficiencies (Exelixis) whereas the other group (DrosDel) only made a few to prove the principle, leaving it up to interested researchers to make their own. I am sure that the Exelixis deficiency set is having a greater impact, though the DrosDel set is useful too, though to a smaller set of workers who need a specific deficiency not available elsewhere.
CONCLUSION
Participating in a truly joint project, particularly when one is a graduate student, is not only a lot of fun but also is valuable training. On the one hand, since everyone does everything, it is an excellent opportunity to learn techniques one might otherwise never get around to, from people who not only know them but are doing them with you; on the other hand, a group that contains all the various levels can be an eye-opener. Post docs and heads of laboratories can make mistakes too! LITERATURE CITED Baker, B. S., 1975 Paternal loss (pal) :A meiotic mutantin D. melanogaster causing loss of paternal chromosomes. Genetics 80: 267-296.
